Abstract
Within a few weeks of the novel coronavirus genome sequence being published, numerous therapies and vaccines have entered clinical trials with a few showing great promise in alleviating symptoms and accelerating recovery.
Asher Mullard (2020)
COVID-19 vaccine development pipeline gears upLancet (London, England), 395
P. Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-rui Si, Yan Zhu, Bei Li, Chao Huang, Hui-Dong Chen, Jing Chen, Yun Luo, Hua Guo, Ren-di Jiang, Mei Liu, Ying Chen, Xurui Shen, Xi Wang, Xiao-Shuang Zheng, Kai Zhao, Quanjiao Chen, F. Dèng, Lin-lin Liu, Bing-Ru Yan, F. Zhan, Yan-Yi Wang, Geng-Fu Xiao, Z. Shí (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 579
C. Harrison (2020)
Coronavirus puts drug repurposing on the fast trackNature Biotechnology, 38
(2020)
Credit: Andrey Deryabin/Alamy Stock Photo
Within a few weeks of the novel coronavirus genome sequence being published, numerous therapies and vaccines have entered clinical trials with a few showing great promise in alleviating symptoms and accelerating recovery.
Nature Materials – Springer Journals
Published: Aug 23, 2020
Access the full text.
Sign up today, get DeepDyve free for 14 days.